Peptide therapy 'scares': what the safety data actually shows

What did @jacobnach actually say?

Jacob says he accidentally injected ten times his intended dose of Melanotan II, mistaking it for a different peptide. He describes the compound as one developed to produce melanin "without sun exposure" by targeting melanocyte cells. He also claims it activates MC3R and MC4R receptors, producing appetite suppression and erectile effects, and that this makes it uniquely marketable. He frames the overdose as a transparency moment.

To his credit, he does not claim this cured a disease. He positions it primarily as a tanning and cosmetic compound, with the other effects described as secondary. That framing is broadly consistent with how Melanotan II is discussed in the literature, even if the delivery lacks some important nuance. The personal anecdote about surviving a tenfold overdose, while alarming, is not implausible given what researchers have documented about dose-dependent side effects at high exposure.

Does the science back this up?

Mostly yes, but with significant gaps. Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). The receptor biology he describes is real. The problem is he makes it sound cleaner than it is.

The compound does act on melanocortin receptors, including MC1R (pigmentation), MC3R and MC4R (metabolic and sexual function). Wessells et al. (2000, International Journal of Impotence Research) confirmed erectogenic effects via MC4R in a small double-blind trial. King et al. (2007, Peptides) documented dose-dependent nausea, flushing, and spontaneous erections at doses as low as 0.025 mg/kg. A tenfold overdose of a standard 0.5-1mg injection would land someone well into the range where nausea, facial flushing, hypotension, and involuntary erections are documented outcomes. Jacob casually describes "weird changes" without naming those specific adverse effects, which undersells the actual risk profile.

The claim that it was "developed in order to create a way for the body to produce melanin without sun exposure" is a reasonable lay summary. The University of Arizona originally synthesized it partly to explore photoprotection. Hadley and Dorr (2006, Peptides) confirm that origin story. So on mechanism, he's not wrong. He's just incomplete.

What did they get wrong (or right)?

He got the receptor targets right. MC3R and MC4R involvement in appetite and sexual arousal is well-documented. The origin story about melanin production without UV exposure is accurate in broad strokes.

What he glossed over is more concerning. Melanotan II is not approved by the FDA for any use. Unregulated compounded versions carry real contamination risks. The Therapeutic Goods Administration in Australia has specifically warned about counterfeit and unlicensed Melanotan II products causing serious adverse events. He says it's "one of the few peptides made in the United States" as a quality signal, but place of manufacture does not equal regulatory approval or verified purity.

He also says there are "better options out there in terms of appetite suppression" without naming them, which is vague enough to be harmless but nudges viewers toward exploring compounds that carry their own risk profiles. The ten-times overdose framing, while honest, normalizes a cavalier approach to peptide dosing that could encourage risky experimentation in viewers with far less experience.

What should you actually know?

Melanotan II has a real pharmacological basis. The receptor science is not made up. But the gap between "this compound has documented biological activity" and "this is safe to inject at home from unlabeled vials" is enormous, and that gap never gets addressed in this video.

• Melanotan II is not FDA-approved. It is not legal to sell as a human therapeutic in the U.S.
• Side effects at standard doses include nausea, facial flushing, spontaneous erections, and hypotension. At ten times a standard dose, these effects are expected to be pronounced.
• Mislabeling peptide vials, as Jacob openly admits doing, is a genuine safety hazard. This is not just embarrassing. It is how serious accidental overdoses happen.
• The "made in the USA" quality argument does not substitute for third-party testing or regulatory oversight.
• If you are considering any melanocortin-targeting compound, that conversation belongs with a licensed clinician, not a TikTok comment section.

Is the transparency framing actually useful?

Jacob deserves credit for not hiding this. The point he makes, that influential health creators make mistakes but rarely admit them, is fair and worth saying out loud. The problem is that transparency about a mistake does not automatically make the underlying behavior safe or advisable.

Telling 32,000 viewers "I accidentally injected ten times the dose and I'm fine" carries a normalization risk. Most viewers will hear the survival part more clearly than the mistake part. That is how availability bias works. The responsible version of this video would include a clearer accounting of what adverse effects actually occurred and a direct statement that home peptide injection without medical supervision is not something to replicate.